Luca Cartegni - Search Results

Year	Number of Results
2002	4
2003	2
2004	1
2005	1
2006	1
2007	2
2008	1
2010	2
2011	4
2012	1
2013	3
2014	2
2015	1
2017	2
2021	1
2022	1
2024	0

1

Posttranscriptional Regulation and RNA Binding Proteins in Cancer Biology.

Ghigna C, Cartegni L, Jordan P, Paronetto MP. Ghigna C, et al. Among authors: cartegni l. Biomed Res Int. 2015;2015:897821. doi: 10.1155/2015/897821. Epub 2015 Jul 27. Biomed Res Int. 2015. PMID: 26273657 Free PMC article. No abstract available.

2

Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene, OPRM1: Insight into Complex Mu Opioid Actions.

Liu S, Kang WJ, Abrimian A, Xu J, Cartegni L, Majumdar S, Hesketh P, Bekker A, Pan YX. Liu S, et al. Among authors: cartegni l. Biomolecules. 2021 Oct 15;11(10):1525. doi: 10.3390/biom11101525. Biomolecules. 2021. PMID: 34680158 Free PMC article. Review.

3

Exploring Pharmacological Functions of Alternatively Spliced Variants of the Mu Opioid Receptor Gene, Oprm1, via Gene-Targeted Animal Models.

Kang W, Liu S, Xu J, Abrimian A, Malik AF, Chien R, Adaralegbe A, Amponsah A, Cartegni L, Pintar J, Pan YX. Kang W, et al. Among authors: cartegni l. Int J Mol Sci. 2022 Mar 10;23(6):3010. doi: 10.3390/ijms23063010. Int J Mol Sci. 2022. PMID: 35328429 Free PMC article. Review.

4

U1 snRNP-Dependent Suppression of Polyadenylation: Physiological Role and Therapeutic Opportunities in Cancer.

Spraggon L, Cartegni L. Spraggon L, et al. Among authors: cartegni l. Int J Cell Biol. 2013;2013:846510. doi: 10.1155/2013/846510. Epub 2013 Oct 27. Int J Cell Biol. 2013. PMID: 24285958 Free PMC article. Review.

5

Listening to silence and understanding nonsense: exonic mutations that affect splicing.

Cartegni L, Chew SL, Krainer AR. Cartegni L, et al. Nat Rev Genet. 2002 Apr;3(4):285-98. doi: 10.1038/nrg775. Nat Rev Genet. 2002. PMID: 11967553 Review.

6

Antitumorigenic potential of STAT3 alternative splicing modulation.

Zammarchi F, de Stanchina E, Bournazou E, Supakorndej T, Martires K, Riedel E, Corben AD, Bromberg JF, Cartegni L. Zammarchi F, et al. Among authors: cartegni l. Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17779-84. doi: 10.1073/pnas.1108482108. Epub 2011 Oct 17. Proc Natl Acad Sci U S A. 2011. PMID: 22006329 Free PMC article.

7

In Vitro Modulation of Endogenous Alternative Splicing Using Splice-Switching Antisense Oligonucleotides.

Park JE, Cartegni L. Park JE, et al. Among authors: cartegni l. Methods Mol Biol. 2017;1648:39-52. doi: 10.1007/978-1-4939-7204-3_4. Methods Mol Biol. 2017. PMID: 28766288

8

A preclinical approach for gene therapy of beta-thalassemia.

Breda L, Kleinert DA, Casu C, Casula L, Cartegni L, Fibach E, Mancini I, Giardina PJ, Gambari R, Rivella S. Breda L, et al. Among authors: cartegni l. Ann N Y Acad Sci. 2010 Aug;1202:134-40. doi: 10.1111/j.1749-6632.2010.05594.x. Ann N Y Acad Sci. 2010. PMID: 20712784 Free PMC article.

9

Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas.

Lefave CV, Squatrito M, Vorlova S, Rocco GL, Brennan CW, Holland EC, Pan YX, Cartegni L. Lefave CV, et al. Among authors: cartegni l. EMBO J. 2011 Sep 13;30(19):4084-97. doi: 10.1038/emboj.2011.259. EMBO J. 2011. PMID: 21915099 Free PMC article.

10

Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation.

Vorlová S, Rocco G, Lefave CV, Jodelka FM, Hess K, Hastings ML, Henke E, Cartegni L. Vorlová S, et al. Among authors: cartegni l. Mol Cell. 2011 Sep 16;43(6):927-39. doi: 10.1016/j.molcel.2011.08.009. Mol Cell. 2011. PMID: 21925381 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

27 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year